Log-in
Sign-up
Webcast
Clinical Trials
Library
Webcast
Clinical Trials
Library
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
Completed
NCT00902538
Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension
2,204
Enrollment(s)
0
Study location(s)
Interventional (Phase III)
Essential Hypertension
Completed
NCT00923091
Parallel-Group Comparison of Olmesartan (OLM), Amlodipine (AML) and Hydrochlorothiazid (HCTZ) in Hypertension
2,689
Enrollment(s)
0
Study location(s)
Interventional (Phase III)
Essential Hypertension
Completed
NCT00430950
Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension
1,011
Enrollment(s)
0
Study location(s)
Interventional (Phase III)
Essential Hypertension
Completed
NCT01587651
Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
110
Enrollment(s)
13
Study location(s)
Interventional (Phase IV)
Coronary Artery Disease
Completed
NCT01260584
The Influence of Smoking Status on Prasugrel and Clopidogrel Treated Subjects Taking Aspirin and Having Stable Coronary Artery Disease
110
Enrollment(s)
3
Study location(s)
Interventional (Phase IV)
Coronary Artery Disease
Completed
NCT00791258
A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood Pressure
999
Enrollment(s)
0
Study location(s)
Interventional (Phase IV)
Hypertension
Completed
NCT00649389
Safety and Efficacy Study of a Triple Combination Therapy in Subjects With Hypertension
2,500
Enrollment(s)
0
Study location(s)
Interventional (Phase III)
Hypertension
Completed
NCT00430508
Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension
972
Enrollment(s)
0
Study location(s)
Interventional (Phase III)
Essential Hypertension
66
67
68
69
70